Rep. Scott Peters, Millennium Health and Others Gather to Urge Awareness on Fentanyl Risks as Students Return to School
SAN DIEGO, Calif. – September 5, 2023 – Fentanyl is a deadly synthetic opioid that has infiltrated every community in America, killing tens of thousands along the way, including many children and teens.Read More
August 23, 2023 – Xylazine has emerged as an adulterating agent in many illicit drug products and can have significant adverse effects, including death. Read More
Millennium Health Study Featured at the College on Problems of Drug Dependence
SAN DIEGO, Calif. – June 20, 2023 – Millennium Health is honored to present at this year’s College of Problems of Drug Dependence (CPDD) annual scientific meeting. Read More
Clinicians Identify Buprenorphine “Spiking” In JAMA Psychiatry Study Supported by Millennium Health Researchers
SAN DIEGO, Calif. – March 22, 2023 – A JAMA Psychiatry study, led by Jarratt D. Pytell, MD, MHS, Department of Medicine, University of Colorado School of Medicine, and co-authored by Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, and Millennium Health researchers calls attention to factors associated with patients who have urine drug test (UDT) samples suggestive of buprenorphine “ADD-IN” (commonly referred to as “spiking”). Read More
Fentanyl Is Widening Grip on the Nation as Western Presence and Detection with Other Drugs Increase to Record Highs, Millennium Health Signals Report™ Shows
Fentanyl co-detection in individuals using heroin, prescription opioids, methamphetamine or cocaine reached historic levels in 2022; Drug test data also show evolution of dangerous fentanyl analogues, with geographical differences
SAN DIEGO, Calif. – February 21, 2023 – Detection of fentanyl in urine drug test (UDT) specimens remains near historic highs and fentanyl co-detection in individuals using heroin, prescription opioids, methamphetamine, or cocaine has reached new heights, according to the Millennium Health Signals Report™ released today.
Millennium Health and CDC Collaborate on Detecting Drug Use Trends Using Testing Data
Millennium Health’s real-time data and analytics is designed to help the agency prevent fentanyl and other drug overdose deaths.
SAN DIEGO, Calif. – February 7, 2023 – Millennium Health, a leading drug testing company, announced a multi-year contract to support the Centers for Disease Control and Prevention (CDC) in their efforts to save lives and prevent fatal drug overdoses.Read More
Arizona Experiencing Increase in Illicit Fentanyl Exposure
Millennium Health Releases Emerging Threat Intelligence™ Report to Help Prevent Opioid Overdoses
SAN DIEGO, Calif. – December 8, 2022 – Millennium Health announced today that illicit fentanyl positivity in Arizona increased by 261% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.Read More
Minnesota Experiencing Increase in Illicit Fentanyl Exposure
Millennium Health Releases Emerging Threat Intelligence™ Report to Help Prevent Opioid Overdoses
SAN DIEGO, Calif. – October 20, 2022 – Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.Read More
Washington Experiencing Substantial Increase in Illicit Fentanyl Use for 2022
Millennium Health’s Emerging Threat Intelligence™ Report Finds King and Snohomish Counties Experiencing the Most Significant Increases Statewide
SAN DIEGO, Calif. – September 22, 2022 – A dramatic increase in drug overdose deaths, primarily due to illicit fentanyl, is being reported across the U.S.1 Contributing to these deaths is the proliferation of counterfeit pills often containing fentanyl that are nearly impossible to distinguish from authentic medications.2Read More
Millennium Health and Penn State College of Medicine Poster Presented at PAINWeek Regarding Illicit Drug Use Among People with Chronic Pain
SAN DIEGO, Calif. – September 13, 2022 – A study led by Monika Holbein, MD of Penn State College of Medicine and co-authored by Millennium Health researchers, demonstrated that urine specimens from pain management practices tested positive for heroin, illicit fentanyl, cocaine, and methamphetamine more often in patients who were not being prescribed opioids than for those patients who were prescribed opioids. Read More
Patient Billing
(877) 451-7337
PatientBillingServices@millenniumhealth.com
Monday-Friday 6:00AM-4:00PM PT
Corporate Headquarters
(877) 451-3534
